...
首页> 外文期刊>Washington Drug Letter >Plaintiffs Ask Court to Review Pfizer's Neurontin Documents
【24h】

Plaintiffs Ask Court to Review Pfizer's Neurontin Documents

机译:原告要求法院审查辉瑞公司的Neurontin文件

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Plaintiffs in a class action antitrust lawsuit against Pfizer are asking a district court to review company documents, saying they may show the drugmaker wrongfully tried to delay generic competition for its epilepsy drug Neurontin.rnThe plaintiffs, who are direct purchasers, filed the motion in the U.S. District Court for the District of New Jersey.rnIf a court review finds evidence of crime or fraud in papers related to Pfizer's applications for FDA Orange Book patent listings for Neurontin (gabapentin), the documents could be used at trial, the plaintiffs claim. The court will hear the motion March 15.
机译:在针对辉瑞的集体诉讼反托拉斯诉讼中,原告正要求地方法院审查公司文件,称他们可能表明该制药商错误地试图延迟其癫痫药Neurontin的仿制药竞争。原告称,如果法院的审查发现与辉瑞公司申请的FDA橙皮书Neurontin(gabapentin)专利清单相关的文件中有犯罪或欺诈证据,则该文件可用于审判。法院将在3月15日听取动议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号